Title : Challenge of glass Vials/PFS/Cartridge for biosimilar products

Presently Packaging plays a significant role for Biosimilar products. The process of selecting materials and the type of packaging also offers an opportunity for the Packaging scientist to look for new biological delivery choices. Most injectable protein products were supplied in some sort of glass vial, prefilled syringe, and cartridge. That product having high Ph. content there is a chance of “delamination “from inner surface of glass vial. With protein-based drugs, the biggest issue is the effect of packaging derivatives on the protein’s three-dimensional and surface structure. These are effects that relate to denaturation or aggregation of the protein due to oxidation or interactions from contaminants or impurities in the preparation. The potential for these effects needs to be carefully considered in choosing the container and the container closure system to avoid putting patients in jeopardy.

Anupam Chanda  has his expertise in  creating innovative design in packaging material and device for Biologics, biosimilar , anti Cancer and HIV products. He is having two decades( approx. 32  years) of experience in India and abroad. He is a renowned speaker , widely travel throughout the world. Gain and share his thoughts with scientist from various institution and industry professionals.Author’s Technical book “ Packaging Technology An advance Practical approach “Published from Germany and Amazon is distributing to 77 countries.